Haffty BG - Search Results

1

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Haffty BG, et al. Ann Oncol. 2009 Oct;20(10):1653-9. doi: 10.1093/annonc/mdp051. Epub 2009 Jun 2. Ann Oncol. 2009. PMID: 19491284 Free article.

2

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.

Haffty BG, Silber A, Matloff E, Chung J, Lannin D. Haffty BG, et al. J Med Genet. 2006 Feb;43(2):133-7. doi: 10.1136/jmg.2005.034744. Epub 2005 Jun 27. J Med Genet. 2006. PMID: 15983021 Free PMC article.

3

Cardiovascular toxicities of breast cancer treatment: emerging issues in cardio-oncology.

Goyal S, Haffty BG. Goyal S, et al. Among authors: haffty bg. Front Oncol. 2015 Mar 18;5:66. doi: 10.3389/fonc.2015.00066. eCollection 2015. Front Oncol. 2015. PMID: 25853094 Free PMC article. No abstract available.

4

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Choi DH, et al. Among authors: haffty bg. J Clin Oncol. 2004 May 1;22(9):1638-45. doi: 10.1200/JCO.2004.04.179. J Clin Oncol. 2004. PMID: 15117986

5

Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes.

Choi DH, Lee MH, Haffty BG. Choi DH, et al. Among authors: haffty bg. Breast J. 2006 May-Jun;12(3):216-20. doi: 10.1111/j.1075-122X.2006.00245.x. Breast J. 2006. PMID: 16684319

6

Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.

Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D. Haffty BG, et al. J Clin Oncol. 2006 Dec 20;24(36):5652-7. doi: 10.1200/JCO.2006.06.5664. Epub 2006 Nov 20. J Clin Oncol. 2006. PMID: 17116942

7

The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.

Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG. Choi DH, et al. Among authors: haffty bg. Breast Cancer Res Treat. 2008 Dec;112(3):569-73. doi: 10.1007/s10549-007-9878-z. Epub 2008 Jan 3. Breast Cancer Res Treat. 2008. PMID: 18175216

8

Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.

Yang Q, Moran MS, Haffty BG. Yang Q, et al. Among authors: haffty bg. Breast Cancer Res Treat. 2009 May;115(2):343-8. doi: 10.1007/s10549-008-0068-4. Epub 2008 May 31. Breast Cancer Res Treat. 2009. PMID: 18516673 Clinical Trial.

9

Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy.

Taunk NK, Goyal S, Moran MS, Yang Q, Parikh R, Haffty BG. Taunk NK, et al. Among authors: haffty bg. Radiother Oncol. 2010 Aug;96(2):204-8. doi: 10.1016/j.radonc.2010.03.009. Epub 2010 Mar 24. Radiother Oncol. 2010. PMID: 20338651

10

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy.

Patel AN, Goyal S, Wu H, Schiff D, Moran MS, Haffty BG. Patel AN, et al. Among authors: haffty bg. Breast Cancer Res Treat. 2011 Apr;126(3):601-7. doi: 10.1007/s10549-010-0960-6. Epub 2010 Jun 3. Breast Cancer Res Treat. 2011. PMID: 20521098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters